Oxford Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-267,384
| Closed | -$868K | – | 1736 |
|
|
2019
Q4 | $868K | Sell |
267,384
-191,599
| -42% | -$622K | 0.02% | 951 |
|
|
2019
Q3 | $991K | Sell |
458,983
-224,627
| -33% | -$485K | 0.02% | 945 |
|
|
2019
Q2 | $2.15M | Sell |
683,610
-384,068
| -36% | -$1.21M | 0.05% | 611 |
|
|
2019
Q1 | $3.97M | Buy |
+1,067,678
| New | +$3.97M | 0.09% | 256 |
|
|
2018
Q2 | – | Sell |
-35,326
| Closed | -$104K | – | 2075 |
|
|
2018
Q1 | $104K | Buy |
35,326
+17,522
| +98% | +$51.6K | ﹤0.01% | 1530 |
|
|
2017
Q4 | $51K | Sell |
17,804
-88,242
| -83% | -$253K | ﹤0.01% | 1558 |
|
|
2017
Q3 | $359K | Buy |
+106,046
| New | +$359K | 0.01% | 1299 |
|